SCHEMBL382570

SCHEMBL382570

CC(C)(C)N(OC(=O)CCNC(=O)c1ccc(N2CCC(Nc3nc4ccccc4[nH]3)CC2)cc1)S(=O)(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
KDM4E B2RXH2 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 2/20 0.41
ITGB3 P05106 3/20 0.41
ITGAV P06756 3/20 0.41
ITGA2B P08514 1/20 0.41
CASR P41180 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 2/20 0.38
KCNH2 Q12809 1/20 0.38
ADRB3 P13945 1/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 3/20 0.36
CLK1 P49759 1/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL460322 0.90 ITGB3 (0.40) KDM4ENPC1ALDH1A1ITGB3ITGAV
SCHEMBL7656383 0.85 ITGB3 (0.44) SMN1; SMN2KDM4EALDH1A1ITGB3ITGAV
SCHEMBL383158 0.85 ITGB3 (0.44) SMN1; SMN2KDM4ENPC1RAB9AALDH1A1
SCHEMBL382073 0.84 DRD4 (0.49) KDM4ENPC1ALDH1A1TSHRGAA
SCHEMBL383582 0.82 ITGB3 (0.59) NPC1ALDH1A1ITGB3ITGAVITGA2B
SCHEMBL383466 0.81 CCR5 (0.46) SMN1; SMN2ALDH1A1ITGB3ITGAVITGA2B
SCHEMBL383252 0.80 CASR (0.42) KDM4EALDH1A1ITGB3ITGAVITGA2B
SCHEMBL383350 0.80 CASR (0.42) KDM4EALDH1A1ITGB3ITGAVITGA2B
SCHEMBL382573 0.78 ITGB3 (0.43) SMN1; SMN2KDM4ENPC1RAB9AALDH1A1
SCHEMBL6499244 0.78 CNR1 (0.38) KDM4EALDH1A1ITGB3ITGAVITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed